nodes	percent_of_prediction	percent_of_DWPC	metapath
Calcium Gluceptate—Vasospasm—Carmustine—lymphatic system cancer	0.056	0.056	CcSEcCtD
Calcium Gluceptate—Coma—Fludarabine—lymphatic system cancer	0.0273	0.0273	CcSEcCtD
Calcium Gluceptate—Stupor—Carmustine—lymphatic system cancer	0.0256	0.0256	CcSEcCtD
Calcium Gluceptate—Necrosis—Carmustine—lymphatic system cancer	0.0244	0.0244	CcSEcCtD
Calcium Gluceptate—Abscess—Carmustine—lymphatic system cancer	0.0242	0.0242	CcSEcCtD
Calcium Gluceptate—Necrosis—Mitoxantrone—lymphatic system cancer	0.0227	0.0227	CcSEcCtD
Calcium Gluceptate—Depressed level of consciousness—Carmustine—lymphatic system cancer	0.0185	0.0185	CcSEcCtD
Calcium Gluceptate—Coma—Carmustine—lymphatic system cancer	0.0175	0.0175	CcSEcCtD
Calcium Gluceptate—Coma—Vincristine—lymphatic system cancer	0.0167	0.0167	CcSEcCtD
Calcium Gluceptate—Anorexia—Mechlorethamine—lymphatic system cancer	0.0157	0.0157	CcSEcCtD
Calcium Gluceptate—Arrhythmia—Teniposide—lymphatic system cancer	0.0153	0.0153	CcSEcCtD
Calcium Gluceptate—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.0143	0.0143	CcSEcCtD
Calcium Gluceptate—Arrhythmia—Fludarabine—lymphatic system cancer	0.0134	0.0134	CcSEcCtD
Calcium Gluceptate—Cardiac arrest—Vincristine—lymphatic system cancer	0.0126	0.0126	CcSEcCtD
Calcium Gluceptate—Confusional state—Teniposide—lymphatic system cancer	0.0122	0.0122	CcSEcCtD
Calcium Gluceptate—Oedema—Teniposide—lymphatic system cancer	0.0121	0.0121	CcSEcCtD
Calcium Gluceptate—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.0121	0.0121	CcSEcCtD
Calcium Gluceptate—Stupor—Methotrexate—lymphatic system cancer	0.0119	0.0119	CcSEcCtD
Calcium Gluceptate—Pruritus—Mechlorethamine—lymphatic system cancer	0.0116	0.0116	CcSEcCtD
Calcium Gluceptate—Anorexia—Teniposide—lymphatic system cancer	0.0116	0.0116	CcSEcCtD
Calcium Gluceptate—Hypotension—Teniposide—lymphatic system cancer	0.0113	0.0113	CcSEcCtD
Calcium Gluceptate—Necrosis—Methotrexate—lymphatic system cancer	0.0113	0.0113	CcSEcCtD
Calcium Gluceptate—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.0113	0.0113	CcSEcCtD
Calcium Gluceptate—Abscess—Methotrexate—lymphatic system cancer	0.0112	0.0112	CcSEcCtD
Calcium Gluceptate—Confusional state—Fludarabine—lymphatic system cancer	0.0108	0.0108	CcSEcCtD
Calcium Gluceptate—Oedema—Fludarabine—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Calcium Gluceptate—Decreased appetite—Teniposide—lymphatic system cancer	0.0105	0.0105	CcSEcCtD
Calcium Gluceptate—Vomiting—Mechlorethamine—lymphatic system cancer	0.0105	0.0105	CcSEcCtD
Calcium Gluceptate—Anorexia—Fludarabine—lymphatic system cancer	0.0102	0.0102	CcSEcCtD
Calcium Gluceptate—Feeling abnormal—Teniposide—lymphatic system cancer	0.01	0.01	CcSEcCtD
Calcium Gluceptate—Nausea—Mechlorethamine—lymphatic system cancer	0.00978	0.00978	CcSEcCtD
Calcium Gluceptate—Paraesthesia—Fludarabine—lymphatic system cancer	0.00958	0.00958	CcSEcCtD
Calcium Gluceptate—Decreased appetite—Fludarabine—lymphatic system cancer	0.00927	0.00927	CcSEcCtD
Calcium Gluceptate—Constipation—Fludarabine—lymphatic system cancer	0.00912	0.00912	CcSEcCtD
Calcium Gluceptate—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00909	0.00909	CcSEcCtD
Calcium Gluceptate—Hypersensitivity—Teniposide—lymphatic system cancer	0.00894	0.00894	CcSEcCtD
Calcium Gluceptate—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00879	0.00879	CcSEcCtD
Calcium Gluceptate—Asthenia—Teniposide—lymphatic system cancer	0.00871	0.00871	CcSEcCtD
Calcium Gluceptate—Pruritus—Teniposide—lymphatic system cancer	0.00858	0.00858	CcSEcCtD
Calcium Gluceptate—Arrhythmia—Carmustine—lymphatic system cancer	0.00858	0.00858	CcSEcCtD
Calcium Gluceptate—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.00856	0.00856	CcSEcCtD
Calcium Gluceptate—Diarrhoea—Teniposide—lymphatic system cancer	0.0083	0.0083	CcSEcCtD
Calcium Gluceptate—Coma—Methotrexate—lymphatic system cancer	0.0081	0.0081	CcSEcCtD
Calcium Gluceptate—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00798	0.00798	CcSEcCtD
Calcium Gluceptate—Confusional state—Bleomycin—lymphatic system cancer	0.00788	0.00788	CcSEcCtD
Calcium Gluceptate—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00786	0.00786	CcSEcCtD
Calcium Gluceptate—Oedema—Bleomycin—lymphatic system cancer	0.00782	0.00782	CcSEcCtD
Calcium Gluceptate—Vomiting—Teniposide—lymphatic system cancer	0.00771	0.00771	CcSEcCtD
Calcium Gluceptate—Asthenia—Fludarabine—lymphatic system cancer	0.00765	0.00765	CcSEcCtD
Calcium Gluceptate—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00761	0.00761	CcSEcCtD
Calcium Gluceptate—Pruritus—Fludarabine—lymphatic system cancer	0.00754	0.00754	CcSEcCtD
Calcium Gluceptate—Anorexia—Bleomycin—lymphatic system cancer	0.00745	0.00745	CcSEcCtD
Calcium Gluceptate—Hypotension—Bleomycin—lymphatic system cancer	0.00731	0.00731	CcSEcCtD
Calcium Gluceptate—Diarrhoea—Fludarabine—lymphatic system cancer	0.0073	0.0073	CcSEcCtD
Calcium Gluceptate—Nausea—Teniposide—lymphatic system cancer	0.00721	0.00721	CcSEcCtD
Calcium Gluceptate—Paraesthesia—Bleomycin—lymphatic system cancer	0.00702	0.00702	CcSEcCtD
Calcium Gluceptate—Confusional state—Carmustine—lymphatic system cancer	0.00688	0.00688	CcSEcCtD
Calcium Gluceptate—Oedema—Carmustine—lymphatic system cancer	0.00683	0.00683	CcSEcCtD
Calcium Gluceptate—Decreased appetite—Bleomycin—lymphatic system cancer	0.0068	0.0068	CcSEcCtD
Calcium Gluceptate—Vomiting—Fludarabine—lymphatic system cancer	0.00678	0.00678	CcSEcCtD
Calcium Gluceptate—Oedema—Vincristine—lymphatic system cancer	0.00652	0.00652	CcSEcCtD
Calcium Gluceptate—Anorexia—Carmustine—lymphatic system cancer	0.00651	0.00651	CcSEcCtD
Calcium Gluceptate—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00644	0.00644	CcSEcCtD
Calcium Gluceptate—Confusional state—Mitoxantrone—lymphatic system cancer	0.0064	0.0064	CcSEcCtD
Calcium Gluceptate—Hypotension—Carmustine—lymphatic system cancer	0.00638	0.00638	CcSEcCtD
Calcium Gluceptate—Oedema—Mitoxantrone—lymphatic system cancer	0.00635	0.00635	CcSEcCtD
Calcium Gluceptate—Nausea—Fludarabine—lymphatic system cancer	0.00633	0.00633	CcSEcCtD
Calcium Gluceptate—Shock—Mitoxantrone—lymphatic system cancer	0.00624	0.00624	CcSEcCtD
Calcium Gluceptate—Anorexia—Vincristine—lymphatic system cancer	0.00621	0.00621	CcSEcCtD
Calcium Gluceptate—Paraesthesia—Carmustine—lymphatic system cancer	0.00613	0.00613	CcSEcCtD
Calcium Gluceptate—Hypotension—Vincristine—lymphatic system cancer	0.00609	0.00609	CcSEcCtD
Calcium Gluceptate—Anorexia—Mitoxantrone—lymphatic system cancer	0.00605	0.00605	CcSEcCtD
Calcium Gluceptate—Decreased appetite—Carmustine—lymphatic system cancer	0.00593	0.00593	CcSEcCtD
Calcium Gluceptate—Hypotension—Mitoxantrone—lymphatic system cancer	0.00593	0.00593	CcSEcCtD
Calcium Gluceptate—Paraesthesia—Vincristine—lymphatic system cancer	0.00585	0.00585	CcSEcCtD
Calcium Gluceptate—Constipation—Carmustine—lymphatic system cancer	0.00584	0.00584	CcSEcCtD
Calcium Gluceptate—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00576	0.00576	CcSEcCtD
Calcium Gluceptate—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.0057	0.0057	CcSEcCtD
Calcium Gluceptate—Decreased appetite—Vincristine—lymphatic system cancer	0.00566	0.00566	CcSEcCtD
Calcium Gluceptate—Feeling abnormal—Carmustine—lymphatic system cancer	0.00562	0.00562	CcSEcCtD
Calcium Gluceptate—Asthenia—Bleomycin—lymphatic system cancer	0.00561	0.00561	CcSEcCtD
Calcium Gluceptate—Constipation—Vincristine—lymphatic system cancer	0.00557	0.00557	CcSEcCtD
Calcium Gluceptate—Pruritus—Bleomycin—lymphatic system cancer	0.00553	0.00553	CcSEcCtD
Calcium Gluceptate—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00552	0.00552	CcSEcCtD
Calcium Gluceptate—Constipation—Mitoxantrone—lymphatic system cancer	0.00543	0.00543	CcSEcCtD
Calcium Gluceptate—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00523	0.00523	CcSEcCtD
Calcium Gluceptate—Hypersensitivity—Carmustine—lymphatic system cancer	0.00503	0.00503	CcSEcCtD
Calcium Gluceptate—Vomiting—Bleomycin—lymphatic system cancer	0.00497	0.00497	CcSEcCtD
Calcium Gluceptate—Asthenia—Carmustine—lymphatic system cancer	0.0049	0.0049	CcSEcCtD
Calcium Gluceptate—Hypersensitivity—Vincristine—lymphatic system cancer	0.0048	0.0048	CcSEcCtD
Calcium Gluceptate—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00467	0.00467	CcSEcCtD
Calcium Gluceptate—Asthenia—Vincristine—lymphatic system cancer	0.00467	0.00467	CcSEcCtD
Calcium Gluceptate—Diarrhoea—Carmustine—lymphatic system cancer	0.00467	0.00467	CcSEcCtD
Calcium Gluceptate—Nausea—Bleomycin—lymphatic system cancer	0.00464	0.00464	CcSEcCtD
Calcium Gluceptate—Asthenia—Mitoxantrone—lymphatic system cancer	0.00455	0.00455	CcSEcCtD
Calcium Gluceptate—Dizziness—Carmustine—lymphatic system cancer	0.00451	0.00451	CcSEcCtD
Calcium Gluceptate—Diarrhoea—Vincristine—lymphatic system cancer	0.00446	0.00446	CcSEcCtD
Calcium Gluceptate—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00434	0.00434	CcSEcCtD
Calcium Gluceptate—Vomiting—Carmustine—lymphatic system cancer	0.00434	0.00434	CcSEcCtD
Calcium Gluceptate—Dizziness—Vincristine—lymphatic system cancer	0.00431	0.00431	CcSEcCtD
Calcium Gluceptate—Vomiting—Vincristine—lymphatic system cancer	0.00414	0.00414	CcSEcCtD
Calcium Gluceptate—Nausea—Carmustine—lymphatic system cancer	0.00405	0.00405	CcSEcCtD
Calcium Gluceptate—Vomiting—Mitoxantrone—lymphatic system cancer	0.00403	0.00403	CcSEcCtD
Calcium Gluceptate—Nausea—Vincristine—lymphatic system cancer	0.00387	0.00387	CcSEcCtD
Calcium Gluceptate—Dysgeusia—Methotrexate—lymphatic system cancer	0.00379	0.00379	CcSEcCtD
Calcium Gluceptate—Nausea—Mitoxantrone—lymphatic system cancer	0.00377	0.00377	CcSEcCtD
Calcium Gluceptate—Confusional state—Methotrexate—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Calcium Gluceptate—Anorexia—Methotrexate—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Calcium Gluceptate—Hypotension—Methotrexate—lymphatic system cancer	0.00295	0.00295	CcSEcCtD
Calcium Gluceptate—Paraesthesia—Methotrexate—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Calcium Gluceptate—Decreased appetite—Methotrexate—lymphatic system cancer	0.00275	0.00275	CcSEcCtD
Calcium Gluceptate—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Calcium Gluceptate—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Calcium Gluceptate—Asthenia—Methotrexate—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Calcium Gluceptate—Pruritus—Methotrexate—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Calcium Gluceptate—Diarrhoea—Methotrexate—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Calcium Gluceptate—Dizziness—Methotrexate—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Calcium Gluceptate—Vomiting—Methotrexate—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Calcium Gluceptate—Nausea—Methotrexate—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
